TAK

Takeda Pharmaceutical Company Limited
D

TAK

15.335
USD
-0.11
(-0.68%)
مغلق
حجم التداول
37,654
الربح لكل سهم
134
العائد الربحي
4.34
P/E
66
حجم السوق
47,901,573,362
أصول ذات صلة
AZN
AZN
-1.530
(-2.15%)
69.590 USD
BMY
BMY
-0.525
(-1.10%)
47.080 USD
GILD
GILD
-0.760
(-0.68%)
110.760 USD
GSK
GSK
-0.285
(-0.74%)
38.220 USD
JNJ
JNJ
0.570
(0.37%)
156.110 USD
LLY
LLY
0.55
(0.07%)
779.65 USD
MRK
MRK
-1.370
(-1.66%)
81.010 USD
NVO
NVO
-0.660
(-0.95%)
69.140 USD
NVS
NVS
-1.350
(-1.09%)
122.490 USD
PFE
PFE
0.110
(0.43%)
25.440 USD
SNY
SNY
-0.990
(-2.01%)
48.310 USD
المزيد
الأخبار المقالات

العنوان: Takeda Pharmaceutical Company Limited

القطاع: Healthcare
الصناعة: Drug Manufacturers - Specialty & Generic
Takeda Pharmaceutical is Japan's largest pharmaceutical company, with revenue of JPY 4.6 trillion in fiscal 2024. The company's five core therapeutic areas are oncology, gastroenterology, neuroscience, rare diseases, and plasma-derived therapies, which account for more than 80% of revenue. Its geographic footprint is well diversified, with over 50% derived from the US, 20% from Japan, 20% from Europe and Canada.